Trialing reovirus in combination for I–O applications

Roisin McGuigan, Editor, Immuno-Oncology Insights, speaks to (pictured) Houra Loghmani, Senior Scientist, Oncolytics Biotech, about her role in the development of pelareorep, an intravenously-administered oncolytic virus currently in clinical trials.

Please enter your email to access content Read now